Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Indian FDA Approves the First Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN(R)

en-cphi.cnApril 07, 2017

Tag: Biotechnology , FDA

PharmaSources Customer Service